Episodes
-
When "for better or worse" includes weekly Wegovy shots together.
Discover the unique dynamics, unexpected challenges, and surprising rewards when couples embark on their GLP-1 weight loss journey as a team. From synchronized side effects to navigating different results, this is the real talk about love, needles, and transformation.
Read our companion blog post for this episode:
https://www.glp-1tribe.com/couples-who-inject-together-love-weight-loss-dynamics-on-wegovy-and-zepbound/
What We Cover:Why couples are choosing to start GLP-1s together
Handling the comparison trap when one loses faster
Meal planning when you both can't stand food
Communication strategies that prevent resentment
Creating success without competition
How dramatic weight loss affects intimacy
The 3-2-1 ritual: How injection day becomes bonding timeSafe word system: "Red light" = can't even look at foodDifferent journeys: Same medication ≠ same resultsSocial navigation: Unified responses to judgment and food pushersThe real victory: Supporting each other through ups and downs
Key Insights:
Memorable Quote:"We felt like we'd discovered a secret together. We'd go out to dinner and order one entree to share, giving each other knowing looks when we couldn't finish it. It was like being in on the world's best inside joke."
Couples' Survival Kit Highlights:✅ Weekly check-ins on injection day
✅ No comparing numbers unless both want to
✅ Individual meal prep, shared support
✅ Plan for different responses and timelines
Resources:Check out our free GLP-1 recipe database and free GLP-1 meal planner at https://glp1tribe.com/meal-planner
https://glp1tribe.com/recipes
Whether you're starting together or one partner is joining later, this episode provides real strategies for navigating weight loss as a team while keeping your relationship strong.
-
We have a companion blog post on this episode
Visit our free GLP-1 Meal Planner - https://glp1tribe.com/meal-planner
Struggling to figure out what to eat on GLP-1 meds? You're not alone.
Join 5,000+ people taking our 30-Day Meal Prep Challenge designed specifically for the unique appetite changes on Ozempic, Wegovy, and other GLP-1 medications. No more staring at food wondering why nothing sounds good!
What You'll Learn:🍱 How to meal prep when your appetite is MIA
🥗 The "mix-and-match" system for unpredictable food aversions
💪 Creative protein hacks when meat becomes unappealing
📦 Small-portion prep strategies that actually work
👥 Why community support makes all the difference
Week 1: Find Your New Normal - Discover what works for YOUR bodyWeek 2: Protein Power - Hit your goals when eating feels hardWeek 3: Veggie Victory - Plant-based solutions for meat aversionWeek 4: Sustainable Systems - Build habits that last beyond the challenge
The 30-Day Journey:
Key Takeaways:✅ Prep components, not complete meals, for maximum flexibility
✅ Think "snack-sized meals" instead of traditional portions
✅ Protein first, always - but get creative with sources
✅ Some days you'll eat 3 crackers for dinner, and that's okay
✅ Community support transforms the journey from struggle to success
Sunday protein prep saves the weekKeep portions golf-ball sized, not tennis-ball sizedCold foods often work better than hot when nauseatedBatch cook when you feel good, not when you're hungry
Featured Tips:
Join the Challenge:🌐 Free meal planner at glp1tribe.com/meal-planner
-
Episodes manquant?
-
Want to boost you results? Can't afford Ozempic?
Your grocery store might have the answer.
Discover 11 science-backed foods that naturally boost your body's GLP-1 production – no prescription needed, no insurance battles, just real food that supports your weight loss journey.
Our companion blog post for this episode
https://www.glp-1tribe.com/11-foods-that-naturally-boost-glp-1-natures-ozempic/
What You'll Learn:🥑 How certain foods trigger your body's natural "appetite control" hormone
🔬 The realistic truth about food vs. medication (spoiler: food helps, but isn't magic)
✨ Why fiber + protein + healthy fats = the GLP-1 trifecta
AvocadosEggsGreek Yogurt (full-fat)Leafy GreensSteel-cut OatsLegumes (beans, lentils, chickpeas)Nuts (especially almonds, walnuts)Fatty Fish (salmon, mackerel)BerriesJerusalem ArtichokesFermented Foods (kimchi, sauerkraut)
The 11 GLP-1 Boosting Foods:
Key Takeaway:These foods won't replicate Ozempic's dramatic effects, but they offer a sustainable, affordable way to support your body's own appetite-regulating systems. Perfect for those who can't access medications or want to enhance their current treatment.
Free GLP-1 Foods Shopping List at glp1tribe.comCheck out our free GLP-1 recipe library and GLP1 recipe creator
Resources:
Connect:🌐 glp1tribe.com
📧 [email protected]
Love the show? Leave us a review on Apple Podcasts! ⭐⭐⭐⭐⭐
-
We have a companion blog post on this episode - read it here.
Episode Summary:
Feeling exhausted on GLP-1 medications? You're not alone—but you're not stuck either. In this game-changing episode, we reveal the modified Couch to 5K program specifically designed for Ozempic, Wegovy, and Zepbound users battling fatigue. Discover why 10,000 daily steps can accelerate your weight loss by 30%, learn the exact supplements that combat GLP-1 exhaustion, and get a week-by-week training plan that actually works with your medication (not against it). Whether you walk, jog, or run—this blueprint will get you to that 5K finish line.
Why GLP-1 fatigue is temporary and how to work with it (not through it)The 10,000-step secret that boosts weight loss by 30% on GLP-1sComplete supplement protocol with exact timing for energy optimizationModified 10-week Couch to 5K program designed for GLP-1 usersHow to differentiate between "I can't" and "I don't want to" fatigueWhy walking counts as much as running (and might be better!)Treadmill incline hacks that burn 50% more caloriesThe power of exercise buddies for GLP-1 success
Key Takeaways:Resources Mentioned:
B-Complex vitamins (methylated forms)Magnesium Glycinate (200-400mg)CoQ10 (100-200mg)Electrolyte powders (sugar-free)Step tracking apps (Apple Health, Google Fit, Fitbit)Couch to 5K apps modified for intervalsLocal walking groups and GLP-1 communitiesSuccess Story Highlights:
Sarah: Couldn't walk to mailbox → Completed 5K in 34 minutesTom: Used treadmill inclines exclusively → Lost 95 poundsMaria: Walks every 5K (no running) → Completed 10 races on ZepboundDavid: Formed "GLP-1 Striders" walking group → Lost 80 poundsAction Steps:
Track your energy patterns for one weekStart hydration protocol (80+ oz daily)Order essential supplementsFind one walking buddySchedule three 10-minute walks this weekDownload step tracking appMark calendar for Week 1 start date
Notable Quotes:"You don't have to run a single step to complete a 5K—walking counts!" "The 10-minute rule: If you're exhausted, commit to just 10 minutes." "Every 1% treadmill incline burns 5% more calories." "GLP-1 users who hit 10,000 steps daily lose 30% more weight."
Website: https://glp1tribe.com/
Connect With Us: -
We have a complete blog post on the playbook here for free
This episode offers a comprehensive guide for managing nausea commonly experienced by individuals using GLP-1 medications like Wegovy, Ozempic, and Zepbound.
Drawing on insights from over 50,000 users, it identifies the causes and typical timeline of nausea, emphasizing that it is temporary and manageable. The core of the episode presents 15 "proven hacks", ranging from dietary adjustments like the "Ginger Trinity" and "Temperature Trick" to behavioral strategies such as "Injection Timing Switch" and the "10-10-10 Rule," each with a reported success rate.
It also provides a 24-hour rescue plan and advice on when to seek medical attention, reassuring users that nausea typically subsides significantly within eight weeks.
-
We have a companion blog post on this topic here you can read for free
Before we get into the list we wanted to mention we have a free GLP-1 Recipe generator on our site here
A free GLP-1 Weekly meal planner here that will generate a shopping list for the week for you!And a free GLP-1 Recipe Library that incorporates many of these foods that lessen side effects and help you lose more weight on GLP-1 medications.
This episode offers a strategic approach to managing common side effects experienced by individuals taking GLP-1 medications like Ozempic, Wegovy, or Zepbound. It provides a comprehensive list of 47 specific foods categorized to alleviate symptoms such as nausea, constipation, and fatigue, while also suggesting foods that optimize appetite control. The episode emphasizes that careful food choices are crucial for a comfortable GLP-1 experience, likening the stomach on these medications to a "luxury car in eco-mode" that requires the right fuel.
Practical advice is included for strategic grocery shopping and meal preparation, helping users integrate these beneficial foods into their daily routine for improved well-being and weight loss support.
-
We have a companion blog post for this episode available here to read.
Today's episode "The 100-Pound Club: 7 Non-Negotiable Habits of Extreme GLP-1 Success Stories," outlines key practices that differentiate individuals achieving significant weight loss (100+ pounds) on GLP-1 medications like Ozempic, Wegovy, or Zepbound from those with average results.
We emphasize that these medications are powerful tools, but success hinges on adopting seven "game-changing" habits. These habits include meticulous tracking initially, consistent injection timing, prioritizing high protein intake, engaging in daily movement, proactively managing side effects, cultivating a robust support system, and planning for weight maintenance from the outset. The source frames these habits not as difficult tasks, but as a "blueprint" for maximizing the medication's potential and fostering a lasting lifestyle transformation.
-
We have a companion blog post for this episode - read it here
This episode explores how weight loss medications, specifically GLP-1 receptor agonists like Zepbound, are emerging as a game-changer for sleep apnea treatment, offering an alternative to traditional CPAP therapy. It highlights the significant economic and personal burden of untreated sleep apnea and emphasizes the direct correlation between weight loss and improved sleep apnea severity. Clinical trials demonstrate that these medications not only facilitate substantial weight loss but also lead to dramatic reductions in sleep apnea severity, with many patients experiencing remission or significant improvement. The recent FDA approval of Zepbound for sleep apnea is presented as a crucial development that could improve insurance coverage, making this innovative treatment more accessible to those struggling with the condition.
-
GLP-1 Medications: Efficacy, Safety, and Impact
Read our companion blog post with visuals on this episode
This comprehensive analysis examines the impact of GLP-1 receptor agonists on health, particularly their significant efficacy in weight loss and treatment of diabetes. It highlights studies demonstrating the superior performance of newer dual-agonist medications like Zepbound compared to Wegovy, while also outlining the common gastrointestinal side effects and less frequent but more serious adverse events. Beyond metabolic improvements, the sources explore the expanding therapeutic benefits of GLP-1s, including cardiovascular protection, reduction in addiction behaviors, and positive effects on sleep apnea, kidney function, and even neurological health. Finally, the analysis discusses the rapid adoption of these medications in the U.S. amidst a national obesity and diabetes crisis, noting the high financial burden and existing disparities in access.
-
We have a companion blog post on this topic you can read here.
In this episode we discuss the growing childhood obesity crisis in the United States, highlighting its significant prevalence, health implications, and economic burden. It explores the complex causes, including dietary habits, lack of physical activity, socioeconomic factors, and psychological influences.
We discuss traditional treatment approaches, emphasizing the importance of nutritional changes, increased physical activity, and behavioral support. Finally, it introduces and analyzes the role of GLP-1 medications like Wegovy and Zepbound as potential treatment options for adolescents, weighing their effectiveness, potential side effects, cost, and the need for comprehensive care.
-
Read our companion blog post on this episode
This episode discusses the phenomenon of sagging skin and facial changes, dubbed "Ozempic Face," that can occur after significant and often rapid weight loss, particularly when using GLP-1 medications like Ozempic, Wegovy and Zepbound.
We explain that this issue is caused by fast fat loss and the natural decline of skin elasticity proteins, compounded by factors like age and genetics. The article notes the commonality of these effects and presents various treatment options, ranging from surgical procedures to non-surgical methods like fillers and energy treatments, along with lifestyle adjustments to support skin health. Finally, it touches upon the emotional impact of these physical changes and the growing trend of integrated clinics offering combined weight loss and aesthetic care. -
This episode explains how smart scales go beyond simply measuring total body weight by using Bioelectrical Impedance Analysis (BIA) to estimate various body composition metrics. These metrics, such as body fat percentage, visceral fat, muscle mass, bone mass, body water, protein percentage, Basal Metabolic Rate (BMR), metabolic age, and Fat-Free Body Weight, provide a more comprehensive view of health than weight alone.
We emphasizes that tracking trends in these metrics over time, supported by consistent measurements and companion apps, offers more insightful and motivating feedback for individuals pursuing health goals, although it notes that BIA is not as precise as clinical methods and readings can be influenced by factors like hydration. Ultimately, utilizing these detailed metrics can empower users to make informed lifestyle decisions and focus on overall health gain rather than just weight loss.
We recommend two different digital scales - one at a lower price point and one at a higher price point with more comprehensive features. https://glp1tribe.com/store
You can read our companion blog post on this topic here -
Read the companion blog post to this episode with all the details.In this episode we discuss the often-overlooked psychological impacts of using GLP-1 medications like Ozempic and Wegovy, highlighting that these treatments involve more than just physical changes. They explain the significant "mental load" patients experience, including the profound shift when "food noise" quiets, which can be both liberating and disorienting.
We discuss and explore the complexities of body image as the body changes rapidly, noting issues like loose skin and "phantom fat," and address the potential for emotional fluctuations like anxiety or changes in mood. Finally, they emphasize the importance of seeking support, developing new coping strategies, and adopting a holistic approach to health that integrates both physical and mental well-being on this treatment journey.
Find more support at GLP1 Tribe -
Read our companion blog post on this topic.
This episode provides a guide to maintaining weight loss after using GLP-1 medications. We emphasize that while these medications are effective tools, sustained success requires a multifaceted approach. Key strategies highlighted include continuing medication at a maintenance dose under medical supervision, adopting a sustainable diet focused on whole foods, protein, and fiber, engaging in regular physical activity including strength training, and prioritizing holistic well-being through adequate sleep, stress management, and attention to mental health. We stress that weight maintenance is an ongoing process and should involve collaboration with a healthcare team.
Visit GLP1 Tribe for more info and resources to help with your health journey. -
Why Reducing Visceral Fat with GLP-1s is a Game Changer for Metabolic Health
Read our comprehensive blog post on this topic.The presence of excess visceral fat, often "hidden" deep within the abdomen, poses a significant and often underestimated threat to long-term health. It is far more than an issue of weight; it is an active contributor to serious conditions such as type 2 diabetes, heart disease, liver disease, and potentially even dementia. Understanding its dangers is the first step towards taking proactive measures.
GLP-1 medications have emerged as a promising therapeutic option, offering a new approach not only for weight management but also for specifically targeting this harmful visceral fat and improving overall metabolic health. Their benefits can extend to better blood sugar control, improved cardiovascular risk factors, and potential protection for organs like the kidneys.
However, these medications are most effective when they are part of a comprehensive strategy that includes a commitment to sustainable lifestyle changes. Balanced nutrition, regular physical activity (with a strong emphasis on strength training to preserve muscle mass), adequate sleep, and stress management are crucial partners to GLP-1 therapy. This holistic approach ensures that individuals are not just losing weight but are building a foundation for lasting health.
The journey to better metabolic health is a personal one, and it begins with informed discussion. Individuals concerned about visceral fat or interested in learning more about GLP-1 medications are encouraged to use the information presented here to have productive conversations with their healthcare providers. By understanding their individual risks and the available options, and by actively participating in their care, individuals can take charge of their metabolic health and move towards a healthier future.
-
Follow GLP-1 news and trends on the GLP1Tribe.com web site.
GLP-1 medications were cited as a main example today when Trump signed an executive order saying people in the US should pay the same price to pharma companies as what people in other countries pay for the same medications. I have to agree with the main point in that there hasn't been a great explanation for patients about why people in the US have to pay 5 times as much as people in other countries for the exact same medication.
The order, experts say, is a reimagined and far more aggressive version of Trump’s policy during his first term to cut drug costs, which failed to take effect after a federal judge blocked it.
The administration hasn’t singled out a specific class of drugs for price cuts, but officials said it’s fair to expect that GLP-1s — a class of drugs that includes Ozempic, Wegovy and Zepbound — will be included among them.
The executive order signed today will kick off a round of negotiations with pharma companies who will likely push back on this saying they need to cover their R&D costs.
But I think it is great that the spotlight has been put on this issue.
The central issue is a stark difference in pricing structures. US list prices for these GLP-1 medications are exceptionally high, typically ranging from approximately $935 to $1,349 per month.These figures stand in sharp contrast to prices observed in comparable international markets, where the same medications often cost four to five times less, or even lower in some instances.For example, the US list price for Ozempic ($936) is reported to be over five times higher than in Japan ($169), and the US list price for Wegovy ($1,349) is nearly four times higher than in Germany ($328).
While various patient assistance programs, manufacturer savings cards, and direct-purchase options exist in the US, significantly reducing out-of-pocket costs for certain patient segments – potentially down to $25 per month for some commercially insured individuals or around $499 per month for self-pay vial purchases – these mechanisms do not alter the fundamental high price structure that burdens the overall US healthcare system.This creates a complex landscape of access, where affordability varies dramatically depending on insurance status, income, and program eligibility.
Novo Nordisk (maker of Ozempic and Wegovy) and Eli Lilly (maker of Mounjaro and Zepbound) dominate this multi-billion dollar market. Their pricing strategies appear tailored to exploit the unique dynamics of the US market, characterized by a lack of centralized government price negotiation power compared to peer nations.Other contributing factors to the high US prices include complex patent strategies employed by manufacturers to potentially extend market exclusivity and a pharmaceutical business model increasingly focused on maximizing shareholder returns.
Ultimately, the substantial price differential for these highly effective medications raises critical questions regarding patient access, health equity, and the sustainability of healthcare spending in the United States compared to its international counterparts.
We personally wonder if GLP-1s were 80% less expensive if 20 million more people might take them and if people would take them for longer. If so, the pharma companies would ultimately likely make a lot more money and millions more people would benefit.
-
Read our comprehensive guide to getting insurance coverage and winning insurance appeals.
We created this episode because getting insurance coverage and winning denial appeals can be overwhelming, frustrating, and confusing. Wegovy and Zepbound can costs thousands of dollars a year if you don't get coverage so the stakes are high in getting this coverage many patients.Key Takeaways:
Wegovy and Zepbound offer significant clinical benefits, including substantial weight loss and, for specific patient populations, reduction in cardiovascular risk (Wegovy) or improvement in obstructive sleep apnea (Zepbound). These additional FDA-approved indications can be pivotal for securing coverage, especially under plans like Medicare that restrict coverage for drugs solely for weight loss.
The insurance approval process, particularly prior authorization, is a standard hurdle. Being thoroughly prepared with detailed medical documentation, a comprehensive history of previous weight loss attempts (including diet, exercise, and prior medications), and strong support from a healthcare provider are crucial for a successful PA submission.
Insurance denials are common but not necessarily the final answer. Patients have the right to appeal these decisions, first through internal appeals with the insurer and then, if necessary, through an independent external medical review. Persistence, coupled with a well-documented case addressing the specific reasons for denial, can often lead to an overturned decision. Appeal success rates are significant enough to make the effort worthwhile.
Manufacturer savings programs can substantially reduce out-of-pocket costs for commercially insured patients, both those with and without direct coverage for the medications. However, these programs have limitations, often exclude government beneficiaries, and may not make the drugs affordable for everyone.
If coverage for Wegovy or Zepbound cannot be obtained, alternative FDA-approved weight management medications, comprehensive lifestyle interventions (diet, exercise, behavioral support), and, for appropriate candidates, bariatric surgery remain important and effective options to discuss with a healthcare provider. The field of obesity treatment continues to evolve, with new therapies in clinical trials offering future hope. -
Getting enough fiber is a key to getting good results on a weight loss journey.
In this episode we emphasizes that fiber is an essential nutrient when taking GLP-1 medications like Wegovy, Zepbound, Ozempic, or Mounjaro, going beyond simply managing side effects. It explains that fiber is the indigestible part of plants that benefits digestion, helping to counteract potential constipation caused by these medications and even aiding in blood sugar control and heart health.
This episode discusses the two types of fiber, soluble and insoluble, and provides guidance on gradually increasing intake while staying hydrated, suggesting the Bristol Stool Chart as a tool to monitor effectiveness. Finally, it offers practical tips for incorporating fiber into meals and notes situations where fiber intake might need temporary adjustment.Read our companion blog post on this podcast episode about Fiber
-
Guide to Starting GLP-1 Medications
This episode provides a detailed guide for individuals starting GLP-1 medications like Wegovy, Zepbound, Ozempic, and Mounjaro for weight management. We share 25 practical things people can do when starting on their health journey to better health to get the best results.
View the GLP-1 Tribe blog post on this topic
-
GLP-1 Weight Loss Medication Lab Tests Guide
This episode emphasizes the importance of laboratory testing beyond simply tracking weight on a scale when using GLP-1 medications like Ozempic, Zepbound or Wegovy. It highlights that these medications transform metabolic systems, and bloodwork provides critical insight into how the body is responding and if the medication is working correctly.
The guide details essential lab tests covering glucose metabolism, liver and kidney function, electrolyte balance, lipid profiles, and sometimes thyroid function and nutrition markers. It suggests a structured testing schedule before starting therapy, during early treatment, after dose adjustments, and during stable treatment to monitor improvements and detect potential complications early, stressing that lab data, combined with lifestyle factors and medical oversight, offers a comprehensive picture of health transformation.
Read our companion blog post on this topic
https://www.glp-1tribe.com/essential-lab-tests-for-glp-1-weight-loss-medications-your-complete-guide/ - Montre plus
